China awards country’s first vaccine patent to CanSino

CanSino Biologics has won a patent approval from Beijing for its Ad5-nCOV coronavirus vaccine, which is about to begin Phase III clinical trials in Saudi Arabia. It is the first COVID-19 vaccine patent granted by China, the state-owned People’s Daily reported on Sunday.